EP2760475
Samrunaprótín til að meðhöndla efnaskiptatruflanir
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.9.2012EP published:
4.7.2018EP application number:
12768999.0
EP translation filed:
24.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
25.9.2032Expiry date:
25.9.2026Next due date:
30.9.2026
Title:
FUSION PROTEINS FOR TREATING METABOLIC DISORDERS
Timeline
Today
26.9.2012EP application
4.7.2018EP Publication
24.9.2018Translation submitted
15.10.2018Registration published
25.9.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BOETTCHER, Brian R.Address:
Cambridge, MA, US
Name:
CAPLAN, Shari L.Address:
Cambridge, MA, US
Name:
DANIELS, Douglas S.Address:
Cambridge, MA, US
Name:
HAMAMATSU, NorioAddress:
Cambridge, MA, US
Name:
LICHT, StuartAddress:
Cambridge, MA, US
Name:
WELDON, Stephen CraigAddress:
Cambridge, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161539280 PDate:
26.9.2011Country:
US
Classification
Categories:
A61K 47/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.9.2018
Expires: 25.9.2019
Payer: Árnason Faktor
Number: 8
Paid: 27.8.2019
Expires: 25.9.2020
Payer: Árnason Faktor
Number: 9
Paid: 25.8.2020
Expires: 25.9.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.9.2021
Expires: 25.9.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 12.9.2022
Expires: 25.9.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 12.9.2023
Expires: 25.9.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 10.9.2024
Expires: 25.9.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 14
Paid: 11.9.2025
Expires: 25.9.2026
Payer: G.H. Sigurgeirsson ehf.